Expand mobile version menu
  Skip to main content

Contracts Coordinator

Real-Life Activities

Real-Life Math -- Solution

To determine the cost of the new trial, you'll need to consider all of the important factors.

Five participants are going to receive 1 dose of the drug.
5 participants x 1 dose each x $5 per dose = $25

Three participants will receive 2 doses of the drug.
3 participants x 2 doses each x $5 per dose = $30

Two participants will receive 3 doses.
2 participants x 3 doses x $5 per dose = $30

Total cost = $25 + $30 + $30
Total cost = $85

The new trial will cost $85.

How much more is that than the original trial?

Three participants would have received 1 dose of the drug.
3 participants x 1 dose each x $5 per dose = $15

One participant would have received 2 dosages of the drug.
1 participant x 2 doses each x $5 per dose = $10

One participant would have received 3 doses of the drug.
1 participant x 3 doses each x $5 per dose = $15

Total cost = $15 + $10 + $15
Total cost = $40

Cost difference = $85 - $40
Cost difference = $45

The difference between the costs of the 2 trials is $45.

"If you're going to process more patients in a clinical trial, there will generally be more costs," says Kathy Dunstan. She is a contracts coordinator with a hospital. She adds that most of the calculations aren't this simple, however. They often involve a series of charts and tables.


Contact

  • Email Support

  • 1-800-GO-TO-XAP (1-800-468-6927)
    From outside the U.S., please call +1 (424) 750-3900

Support


Powered by XAP

OCAP believes that financial literacy and understanding the financial aid process are critical aspects of college planning and student success. OCAP staff who work with students, parents, educators and community partners in the areas of personal finance education, state and federal financial aid, and student loan management do not provide financial, investment, legal, and/or tax advice. This website and all information provided is for general educational purposes only, and is not intended to be construed as financial, investment, legal, and/or tax advice.